Highline Wealth Partners »

Crispr Therapeutics shares owned by Highline Wealth Partners

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Highline Wealth Partners from 13F filings

Historical chart of Highline Wealth Partners investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Highline Wealth Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Highline Wealth Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $65k 1.0k 64.81
2025-06-30 $49k 1.0k 48.64
2025-03-31 $34k 1.0k 34.03
2024-12-31 $39k 1.0k 39.36

More positions owned by Highline Wealth Partners

Nvidia Corporation Stock (NVDA)
JPMorgan Ultra-Short Income ETF Etf (JPST)
Janus Henderson AAA CLO ETF Etf (JAAA)
Vanguard S&P 500 ETF Etf (VOO)
Microsoft Corp Stock (MSFT)
Apple Inc Com/Inv Stock (AAPL)
iShares Core MSCI EAFE ETF Etf (IEFA)
Invesco Nasdaq 100 Etf Etf (QQQM)
Schwab Fundamental U.s. Large Company Etf Etf (FNDX)
Meta Platforms Inc Cl A Stock (META)
Vanguard Russell 1000 Value ETF Etf (VONV)
Amazon Stock (AMZN)
Tesla Stock (TSLA)
Costco Whsl Corp/N Stock (COST)
iShares 5-10 Year Investment Grade Corporate Bond ETF Etf (IGIB)

View all positions for Highline Wealth Partners

Top funds holding Crispr Therapeutics

ARK Investment Management
BlackRock
Capital Research and Management Company - Division 3
Orbis Allan Gray
State Street Corporation
T. Rowe Price Investment Management
UBS Group
Vanguard Group
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Geode Capital Management
Susquehanna International
Sr One Capital Management
Citadel Advisors
FMR

View all funds holding Crispr Therapeutics